Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
SHR-1701 Combined with SHR2554 and BP102 for MCRC
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 20
- Registration Number
- NCT06679673
- Locations
- 🇨🇳
Department of Colorectal Surgery Fudan University Shanghai Caner Center, Shanghai, Shanghai, China
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 432
- Registration Number
- NCT06676449
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
HPV Genotype Attribution and Disease Burden of Anal Cancer in China
Not yet recruiting
- Conditions
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 300
- Registration Number
- NCT06670495
To Explore the Effect of Huaier Granule on the Negative Conversion Rate After the CEA Level Increases Again After Colorectal Cancer Surgery
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 134
- Registration Number
- NCT06665334
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
Phase 2
Not yet recruiting
- Conditions
- Interventions
- Drug: Ultrafractionated RT and CGA Guided systemic treatment.Radiation: Ultrafractionated RadiotherapyDrug: PD-1 antibodyDrug: Chemotherapy (CPT-11)Drug: Chemotherapy (Fluorouracil)Drug: Targeted Therapy (anti-VEGF)Drug: Chemotherapy (Raltitrexed)Drug: Targeted Therapy (anti-EGFR)Drug: Chemotherapy (Oxaliplatin)
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 110
- Registration Number
- NCT06665087
Vaccine Chatbot for Improving Influenza Vaccination Uptake
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-10-24
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1200
- Registration Number
- NCT06657573
- Locations
- 🇨🇳
Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang, China
Acute Effects of Cold Exposure on Cognitive Function
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 40
- Registration Number
- NCT06654167
- Locations
- 🇨🇳
Department of Environmental Health, School of Public Health, Fudan University, Shanghai, Shanghai, China
Combination of TURP and Standard Systemic Therapy for MPCa
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 200
- Registration Number
- NCT06655259
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients
Active, not recruiting
- Conditions
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 500
- Registration Number
- NCT06655545
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Cola Ingestion for Esophageal Bolus Impaction
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 50
- Registration Number
- NCT06652620
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath